Mamotest
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $3.3M
Investors
- 5
About Mamotest
Based in Argentina, and founded in 2013, Mamotest provides an AI platform for the diagnosis of breast cancer in patients. As of 2023, the company is headed by its CEO Guillermo Pepe. The company offers an artificial intelligence-based platform for early screening and diagnosis of breast cancer. The firm provides a wide range of services such as 3D mammography, breast ultrasound, stereotactic biopsy, and many others services.
Who invested in Mamotest
5 investors across 1 round
See all investors in Mamotest
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 27, 2023
Amount
$3.3M
Investors
Questions about Mamotest
Who invested in Mamotest?
Mamotest has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mamotest raised?
Mamotest has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mamotest last raise money?
Mamotest's most recent round on record is a Series A, in Mar 2023.
What does Mamotest do?
Based in Argentina, and founded in 2013, Mamotest provides an AI platform for the diagnosis of breast cancer in patients.
Where is Mamotest headquartered?
Mamotest is headquartered in Buenos Aires, Argentina.
Which VCs invest in companies like Mamotest?
Among active investors with capital left to deploy, Crescera Capital, DNA Capital, Eurofarma Ventures and Vox Capital back healthcare companies at Mamotest's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Mamotest? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.